Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Brahmi Capsule is an Ayurvedic herbal supplement developed and manufactured by Kottakkal Arya Vaidya Sala. Each capsule contains 250 mg of *Bacopa monnieri* extract, a traditional herb renowned in Ayurveda for its 'Medhya' (cognitive-enhancing) properties. The product functions as a herbal nootropic and neuromodulator, indicated for supporting memory, concentration, and mental clarity. It is used to address cognitive impairment, learning difficulties, behavioral issues, and potentially Alzheimer's disease. Its mechanism of action is attributed to the modulation of neurotransmitter levels, specifically serotonin and dopamine, alongside providing antioxidant protection to brain cells and reducing neuroinflammation and oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Brahmi Capsule.